39 peer-reviewed studies · Evidence score: 9/10
Evans JR et al. • The Cochrane database of systematic reviews (2023)
Moderate-certainty evidence suggests that antioxidant vitamin and mineral supplementation (AREDS: vitamin C, E, beta-carotene, and zinc) probably slows down progression to late AMD.
Li SS et al. • Seminars in ophthalmology (2022)
Taking multivitamin supplementation may not prevent the development of late AMD.
Wilson LM et al. • Advances in nutrition (Bethesda, Md.) (2021)
Our objective was to determine a minimum concentration of lutein/zeaxanthin intake that is associated with a statistically significant and/or clinically important change in macular pigment optical ...
Chu YC et al. • International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition (2024)
Lutein supplementation may benefit DED patients by improving symptoms and tear film stability.
Pameijer EM et al. • Acta ophthalmologica (2022)
Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.
Leermakers ET et al. • The American journal of clinical nutrition (2016)
Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health.
Ma L et al. • British Journal of Nutrition (2012)
Lutein and zeaxanthin supplementation significantly increased macular pigment optical density.
Choo YM et al. • The Cochrane database of systematic reviews (2025)
While supplementation with lutein and zeaxanthin from day one of life in preterm infants until discharge probably reduces the incidence of ROP stage 3 and above, it may have little or no effect on the incidence of ROP at any stage, IVH or NEC, or mortality assessed throughout the NICU stay.
Khalighi Sikaroudi M et al. • Journal of the science of food and agriculture (2021)
Further clinical trials are required to confirm the results of this study. © 2021 Society of Chemical Industry.
Natarelli N et al. • Journal of medicinal food (2025)
Future research is necessary to determine optimal dosing and supplementation duration for intended photoprotective outcomes.
Hu W et al. • Advances in nutrition (Bethesda, Md.) (2024)
Especially, the L + zeaxanthin + fatty acid combination was ranked best for macular pigment optical density (surface under the cumulative ranking: 99.3%) and second best for contrast sensitivity at...
Hu B et al. • Food & function (2024)
However, for malignant diseases such as liver cancer, it did not show the significant effects of carotenoid supplementation.
Cota F et al. • The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2022)
It may reduce the number of transfusions but this result has to be assessed in a separate ad hoc trial.
Ponce-García V et al. • Seminars in ophthalmology (2024)
Lutein and zeaxanthin accumulation plays an important role during the maturational stage and childhood development.
Kai JY et al. • The British journal of ophthalmology (2023)
Smoking as a risk factor for cataract was the most robust association we identified.
Hu W et al. • Nutrition reviews (2023)
Intake of xanthophyll-rich food or supplements can improve eye health.
Ghasemi F et al. • Prostaglandins & other lipid mediators (2023)
L/Z administration could be an effective treatment for improving circulating HDL-C concentration in elderly adults.
Hajizadeh-Sharafabad F et al. • Critical reviews in food science and nutrition (2022)
The overall results supported possible protective effects of carotenoids on inflammatory biomarkers.
Lem DW et al. • Nutrients (2021)
The data suggest that carotenoid vitamin therapy exerts synergic neuroprotective benefits and has the capacity to serve adjunctive therapy in the management of glaucoma.
Lem DW et al. • Nutrients (2021)
These findings provide a strong molecular basis and a line of evidence that suggests carotenoid vitamin therapy may offer enhanced neuroprotective effects with therapeutic potential to function as an adjunct nutraceutical strategy for management of diabetic retinopathy.